tradingkey.logo
tradingkey.logo

Lifecore Biomedical Reports Financial Results For The Fourth Quarter And Transition Period Ended December 31, 2025, And Provides Corporate Update

ReutersMar 16, 2026 12:17 PM

- Lifecore Biomedical Inc LFCR.O:

  • LIFECORE BIOMEDICAL REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND TRANSITION PERIOD ENDED DECEMBER 31, 2025, AND PROVIDES CORPORATE UPDATE

  • LIFECORE BIOMEDICAL INC - EXPECTS 2026 REVENUE $120-$125 MILLION; ADJUSTED EBITDA $20.5-$25 MILLION

  • LIFECORE BIOMEDICAL INC - Q4 REVENUE $35.7 MILLION

  • LIFECORE BIOMEDICAL INC: Q4 EPS $-0.16

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI